Journal of Thoracic Oncology

August 2007 - Volume 2 - Supplement 4 8

Email to a Colleague

Your Name: (optional)

Your Email:

Colleague's Email:

Separate multiple e-mails with a (;).

Message:
Thought you might appreciate this item(s) I saw at Journal of Thoracic Oncology.

Send a copy to your email

Your message has been successfully sent to your colleague.

Some error has occurred while processing your request. Please try after some time.

• Invited Speakers: Plenary Abstracts: Tobacco or Health? Mon, Sept 3, 08:15 - 10:00
• Invited Speakers: Plenary Abstracts: Tobacco or Health?, Mon, Sept 3, 08:15 - 10:00
• Invited Speakers: Plenary Abstracts: Advances in Staging, Tue, Sept 4, 08:15 - 10:00
• Invited Speakers: Plenary Abstracts: Advances in Management of NSCLC, Thur, Sept 6, 08:15 - 10:00
• Invited Speakers: Mini Symposium Abstracts: Session M01: Surgery in Special Situations: Surgery in Special Situations, Mon, Sept 3, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M02: Translational Research in Radiation Oncology: Translational Research in Radiation Oncology, Mon, Sept 3, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M03: Molecular Predictors of EGFR TKIs: Molecular Predictors of EGFR TKIs, Mon, Sept 3, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M04: Dilemmas of Advanced Technology: Dilemmas of Advanced Technology, Mon, Sept 3, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M05: Characterization of Pulmonary Nodules: Characterization of Pulmonary Nodules, Mon, Sept 3, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M06: Molecular Predictors and Prognosticators: Molecular Predictors and Prognosticators, Mon, Sept 3, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M06: Molecular Predictors and Prognosticators: Molecular Predictors and Prognosticators Mon, Sept 3, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M07: Debate in Lung Cancer Surgery: Debate in Lung Cancer Surgery, Tue, Sept 4, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M08: Predictors for chemotherapy (toxicity and response): Predictors for chemotherapy (toxicity and response), Tue, Sept 4, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M08: Predictors for chemotherapy (toxicity and response): Predictors for chemotherapy (toxicity and response), Tuesday, Sept 4
• Invited Speakers: Mini Symposium Abstracts: Session M09: Lung Cancer Staging: State-of-the-Art Imaging Modality: LC Staging: State-of-the-Art Imaging Modality, Tue, Sept 4, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M10: Emerging Field of Lung Cancer Research: Emerging Field of Lung Cancer Research, Tue, Sept 4, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M11: Chemoprevention: Chemoprevention, Tue, Sept 4, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M12: EGFR/VEGF - Inhibitors in Combination with other Modalities: EGFR/VEGF - Inhibitors in Comb. w/o Modalities, Tue, Sept 4, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M12: EGFR/VEGF - Inhibitors in Combination with other Modalities: EEGFR/VEGF - Inhibitors in Comb. w/o Modalities, Tue, Sept 4, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M12: EGFR/VEGF - Inhibitors in Combination with other Modalities: How to Stage the Mediastinum, Thur, Sept 6, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M15: Genetics and Epigenetics in Lung Carcinogenesis: Genetics and Epigenetics in Lung Carcinogenesis, Thur, Sept 6, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M16: Lung Cancer in Women: Lung Cancer in Women, Tue, Sept 4, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M17: Novel Vaccines and Immunotherapy: Novel Vaccines and Immunotherapy, Thur, Sept 6, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M18: Hot Issues in the Management of Brain Metastases: Hot Issues in the Management of Brain Metastases, Thur, Sept 6, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M19: Bimodality vs. Trimodality in Stage III NSCLC: Bimodality vs. Trimodality in Stage III NSCLC, Thur, Sept 6, 10:30 - 12:00
• Invited Speakers: Mini Symposium Abstracts: Session M20: Patients - Health Care Provider Communication: Patients - Health Care Provider Communication, Thur, Sept 6, 10:30 - 12:00
• Invited Speakers: Education Session Abstracts: Session E01: Mesothelioma: Mesothelioma, Mon, Sept 3, 16:00 - 17:30
• Invited Speakers: Education Session Abstracts: Session E02: Molecular Oncology: Implications for Clinical Practice: Molecular Oncology: Implications for Cl. Practice, Mon, Sept 3, 16:00 - 17:30
• Invited Speakers: Education Session Abstracts: Session E02: Molecular Oncology: Implications for Clinical Practice: Molecular Oncology: Implications for Clinical Practice, Sept 3, 16:00 - 17:30
• Invited Speakers: Education Session Abstracts: Session E03: What's new in Systemic Therapy?: What's new in Systemic Therapy? Mon, Sept 3, 16:00 - 17:30
• Invited Speakers: Education Session Abstracts: Session E04: Advances in Surgical Staging: Advances in Surgical Staging, Mon, Sept 3, 16:00 - 17:30
• Invited Speakers: Education Session Abstracts: Session E05: IASLC Staging Project: IASLC Staging Project, Mon, Sept 3, 16:00 - 17:30
• Invited Speakers: Education Session Abstracts: Session E06: Management of Bone Metastasis: Management of Bone Metastasis, Mon, Sept 3, 16:00 - 17:30
• Invited Speakers: Education Session Abstracts: Session E07: Treatment of Locally Advanced NSCLC: Treatment of Locally Advanced NSCLC, Mon, Sept 3, 16:00 - 17:30
• Invited Speakers: Education Session Abstracts: Session E08: New Technology for Diagnosis: New Technology for Diagnosis, Tue, Sept 4, 16:00 - 17:30
• Invited Speakers: Education Session Abstracts: Session E09: Adjuvant Treatment for Resectable Lung Cancer: Adjuvant Treatment for Resectable Lung Cancer, Tue, Sept 4, 16:00 - 17:30
• Invited Speakers: Education Session Abstracts: Session E10: Comprehensive Symptom Management in Advanced Lung Cancer: Comprehensive Symptom Mgmt in Advanced LC, Tue, Sept 4, 16:00 - 17:30
• Invited Speakers: Education Session Abstracts: Session E11: Controversy in Small Cell Lung Cancer: Controversy in Small Cell Lung Cancer, Tue, Sept 4, 16:00 - 17:30
• Invited Speakers: Education Session Abstracts: Session E12: Recent Advances and Future Prospective in Lung Cancer Pathology: Recent Adv and Future Prospective in LC Pathology, Tue, Sept 4, 16:00 - 17:30
• Invited Speakers: Education Session Abstracts: Session E13: Insights into Thymic Epithelial Tumor: Insights into Thymic Epithelial Tumor, Tue, Sept 4, 16:00 - 17:30
• Invited Speakers: Education Session Abstracts: Session E14: State-of-the-Art Innovation in Radiation Therapy: State-of-the-Art Innovation in Radiation Therapy, Tue, Sept 4, 16:00 - 17:30
• Invited Speakers: Meet the Professor Session Abstracts: Lung Cancer Screening, Mon, Sept 3, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: Bronchioloalveolar Carcinoma (BAC), Mon, Sept 3, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: VATS Minimally Invasive & Robotic Surgery, Mon, Sept 3, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: Small Cell Lung Cancer Therapy, Mon, Sept 3, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: Clinical Trial Methodology for Targeted Agents, Mon, Sept 3, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: Combined Modality Therapy for NSCLC, Tue, Sept 4, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: Non-Surgical Approaches (RFA), Tue, Sept 4, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: Interventional Pulmonology, Tue, Sept 4, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: EGFR-Targeted Therapy, Tue, Sept 4, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: Pulmonary Toxicity of Therapy, Tue, Sept 4, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: Genomics and Proteomics in Lung Cancer, Tue, Sept 4, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: Indications and Limitations of Bronchoscopy, Wed, Sept 5, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: Fraction, Volume Dose in Radiation Therapy, Wed, Sept 5, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: Treatment of Elderly & Poor Performance Patients, Wed, Sept 5, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: Adequate Lymph Node Mapping, Wed, Sept 5, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: Palliative Care of Lung Cancer, Wed, Sept 5, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: Non EGFR, Non Angiogenesis Inhibitors, Wed, Sept 5, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: Advanced Surgical Techniques, Thur, Sept 6, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: Image-Guided Radiation Therapy, Thur, Sept 6, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: NSCLC Therapy: How much and how long? Thur, Sept 6, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: Neuroendocrine Tumors, Thur, Sept 6, 07:00 - 08:00
• Invited Speakers: Meet the Professor Session Abstracts: Salvage Therapy for NSCLC, Thur, Sept 6, 07:00 - 08:00
• Invited Speakers: Biostatistics & Clinical Design Workshop: Biostatistics & Clinical Design Workshop, Sat, Sept 1, 13:00-18:00
• Invited Speakers: Young Investigators Day: Young Investigators Day, Sat, Sept 1, 08:30 - 16:40
• Invited Speakers: Young Investigators Day, Sat, Sept 1, 08:30 - 16:40
• Presidential Symposium Abstracts: Presidential Symposium, Wed, 8:15 - 10:00
• Presidential Symposium Abstracts: Invited Speakers: Presidential Symposium, Wed, 8:15 - 10:00
• Proffered Paper Abstracts: Session A1: Combined Modality Therapy in NSCLC I, Monday, September 3: Combined Modality Therapy in NSCLC I, Mon, 13:45 - 15:30
• Profferred Paper Abstracts: Session A2: Imaging - Prognostic Determinants: Monday, September 3: Imaging - Prognostic Determinants, Mon, 13:45 - 15:30
• Profferred Paper Abstracts: Session A3: Cytotoxic Chemotherapy I: Monday, September 3: Cytotoxic Chemotherapy I, Mon, 13:45 - 15:30
• Profferred Paper Abstracts: Session A4: Surgery: Monday, September 3: Surgery, Mon, 13:45 - 15:30
• Profferred Paper Abstracts: Session A5: Molecular Targets: Monday, September 3: Surgery, Mon, 13:45 - 15:30
• Profferred Paper Abstracts: Session A6: Cancer Genetics and Tumor Biology: Monday, September 3: Molecular Targets, Mon, 13:45 - 15:30
• Profferred Paper Abstracts: Session A6: Cancer Genetics and Tumor Biology: Monday, September 3: Cancer Genetics and Tumor Biology, Mon, 13:45 - 15:30
• Profferred Paper Abstracts: Session A7: Prevention & Early Detection: Monday, September 3: Prevention & Early Detection, Mon, 13:45 - 15:30
• Profferred Paper Abstracts: Session B1: Novel Therapeutics I: Tuesday, September 4: Novel Therapeutics I, Tue, 13:45 - 15:30
• Profferred Paper Abstracts: Session B2: Cytotoxic Chemotherapy II: Tuesday, September 4: Cytotoxic Chemotherapy II, Tue, 13:45 - 15:30
• Profferred Paper Abstracts: Session B3: Molecular Targeted Therapy: EGFR Inhibitors: Tuesday, September 4: Molecular Targeted Therapy: EGFR Inhibitors, Tue, 13:45 - 15:30
• Profferred Paper Abstracts: Session B4: Prevention & Early Detection: + Epidemiology: Tuesday, September 4: Prevention & Early Detection + Epidemiology, Tue, 13:45 - 15:30
• Profferred Paper Abstracts: Session B5: NSCLC: New Paradigm in: Radiation Therapy: Tuesday, September 4: NSCLC: New Paradigm in Radiation Therapy, Tue, 13:45 - 15:30
• Profferred Paper Abstracts: Session B6: Health Services, Supportive Care & QOL: Tuesday, September 4: Health Services, Supportive Care & QOL, Tue, 13:45 - 15:30
• Profferred Paper Abstracts: Session B7: BSTB: Molecular Diagnostics & Pathology: Tuesday, September 4: BSTB: Molecular Diagnostics & Pathology, Tue, 13:45 - 15:30
• Profferred Paper Abstracts: Session C1: Molecular Targeted Therapy: Beyong EGFR: Wednesday, September 5: Molecular Targeted Therapy: Beyong EGFR, Wed, 10:30 - 12:15
• Profferred Paper Abstracts: Session C2: Staging Efficacy: Wednesday, September 5: Staging Efficacy, Wed, 10:30 - 12:15
• Profferred Paper Abstracts: Session C3: Combined Modality Therapy in NSCLC II: Wednesday, September 5: Combined Modality Therapy in NSCLC II, Wed, 10:30 - 12:15
• Profferred Paper Abstracts: Session C4: Chest Medicine: Wednesday, September 5: Chest Medicine, Wed, 10:30 - 12:15
• Profferred Paper Abstracts: Session C4: Chest Medicine: Wednesday, September 5:: Chest Medicine, Wed, 10:30 - 12:15
• Profferred Paper Abstracts: Session C5: Mesothelioma: Wednesday, September 5: Mesothelioma, Wed, 10:30 - 12:15
• Profferred Paper Abstracts: Session C6: Cancer Genetics: Wednesday, September 5: Cancer Genetics, Wed, 10:30 - 12:15
• Profferred Paper Abstracts: Session C7: Tumor & Cell Biology: Wednesday, September 5: Tumor & Cell Biology, Wed, 10:30 - 12:15
• Proffered Paper Abstracts: Session C7: Tumor & Cell Biology, Wednesday, September 5: Tumor & Cell Biology, Wed, 10:30 - 12:15
• Proffered Paper Abstracts: Session C8: Epidemiology & Tobacco Control, Wednesday, September 5: Epidemiology & Tobacco Control, Wed, 10:30 - 12:15
• Proffered Paper Abstracts: Session C9: NSCLC-Surgery, Wednesday, September 5: NSCLC-Surgery, Wed, 10:30 - 12:15
• Proffered Paper Abstracts: Session D1: SCLC, Thursday, September 6: SCLC, Thu, 12:30 - 14:15
• Proffered Paper Abstracts: Session D2: Molecular Targeted Therapy: Biomarkers, Thursday, September 6: Molecular Targeted Therapy: Biomarkers, Thu, 12:30 - 14:15
• Proffered Paper Abstracts: Session D3: Pharmacogenomics & Biomarker in Cytotocix Chemotherapy, Thursday, September 6: Pharmacogenomics & Biomarker in Cytotocix Chemotherapy, Thu, 12:30 - 14:15
• Proffered Paper Abstracts: Session D4: Pathology, Thursday, September 6: Pathology, Thu, 12:30 - 14:15
• Proffered Paper Abstracts: Session D5: Prognostic Factors, Thursday, September 6: Prognostic Factors, Thu, 12:30 - 14:15
• Proffered Paper Abstracts: Session D6: Molecular Biology & Prognostic Factors, Thursday, September 6: Molecular Biology & Prognostic Factors, Thu, 12:30 - 14:15
• Proffered Paper Abstracts: Session D7: Novel Therapeutics II, Thursday, September 6: Novel Therapeutics II, Thu, 12:30 - 14:15
• Poster Discussion Abstracts: Session PD1: Monday, September 3, Epidemiology and Prevention & Early Detection: Epidemiology and Prevention & Early Detection, Mon, 16:00 - 17:30
• Poster Discussion Abstracts: Session PD1: Monday, September 3, Epidemiology and Prevention & Early Detection: EUS and PET-CT in Lung Cancer Staging, Mon, 16:00 - 17:30
• Poster Discussion Abstracts: Session PD1: Monday, September 3, Epidemiology and Prevention & Early Detection: Pathology and Bronchoscopy, Mon, 16:00 - 17:30
• Poster Discussion Abstracts: Session PD6: Monday, September 3, Small Cell Lung Cancer: SCLC, Mon, 16:00 - 17:30
• Poster Discussion Abstracts: Session PD6: Monday, September 3, Small Cell Lung Cancer: Mesothelioman and Other Thoracic Malignancy, Mon, 16:00 - 17:30
• Poster Discussion Abstracts: Session PD6: Monday, September 3, Small Cell Lung Cancer: Supportive Care & QOL, Mon, 16:00 - 17:30
• Poster Discussion Abstracts: Session PD2: Tuesday, September 4, Cancer Genetics and Tumor Biology: Cancer Genetics and Tumor Biology, Tue, 16:00 - 17:30
• Poster Discussion Abstracts: Session PD2: Tuesday, September 4, Cancer Genetics and Tumor Biology: Molecular Pathology, Tue, 16:00 - 17:30
• Poster Discussion Abstracts: Session PD2: Tuesday, September 4, Cancer Genetics and Tumor Biology: Molecular Targets and Prognostic Factors, Tue, 16:00 - 17:30
• Poster Discussion Abstracts: Session PD4: Tuesday, September 4, Combined Modality Therapy in NSCLC: Combined Modality Therapy in NSCLC, Tue, 16:00 - 17:30
• Poster Discussion Abstracts: Session PD4: Tuesday, September 4, Combined Modality Therapy in NSCLC: Cytotoxic Chemotherapy I, Tue, 16:00 - 17:30
• Poster Discussion Abstracts: Session PD4: Tuesday, September 4, Combined Modality Therapy in NSCLC: Cytotoxic Chemotherapy II, Tue, 16:00 - 17:30
• Poster Discussion Abstracts: Session PD2 and PD4 4 PD -Tuesday, September 4: Cytotoxic Chemotherapy II, Tue, 16:00 - 17:30
• Poster Discussion Abstracts: Session PD3 and PD5 PD -Thursday, September 6: Session PD3: Thursday, September 6 Novel Therapeutics: Novel Therapeutics, Thu, 12:30 - 14:15
• Poster Discussion Abstracts: Session PD3 and PD5 PD -Thursday, September 6: Session PD3: Thursday, September 6 Novel Therapeutics: Molecular Targeted Therapy: EGFR inhibitors, Thu, 12:30 - 14:15
• Poster Discussion Abstracts: Session PD3 and PD5 PD -Thursday, September 6: Session PD3: Thursday, September 6 Novel Therapeutics: Molecular Targeted Therapy: Beyond EGFR Inhibitors, Thu, 12:30 - 14:15
• Poster Discussion Abstracts: Session PD3 and PD5 PD -Thursday, September 6: Session PD5: Thursday, September 6 Technical Advances on Radiation Therapy: Technical Advances on Radiation Therapy, Thu, 12:30 - 14:15
• Poster Discussion Abstracts: Session PD3 and PD5 PD -Thursday, September 6: Session PD5: Thursday, September 6 Technical Advances on Radiation Therapy: Clinical Data from Radiation Therapy, Thu, 12:30 - 14:15
• Poster Discussion Abstracts: Session PD3 and PD5 PD -Thursday, September 6: Session PD5: Thursday, September 6 Technical Advances on Radiation Therapy: NSCLC-Surgery, Thu, 12:30 - 14:15
• Poster Discussion Abstracts: Session PD3 and PD5 PD -Thursday, September 6: Session PD5: Thursday, September 6 Technical Advances on Radiation Therapy: NSCLC-SurgeryNSCLC-Surgery, Thu, 12:30 - 14:15
• Poster Abstracts: BSTB: Cancer Genetics: BSTB: Cancer Genetics Posters, Tue, Sept 4
• Poster Abstracts: BSTB: Cancer Genetics: BSTB: Cancer Genetics Posters, Tuesday, Sept 4
• Poster Abstracts: BSTB: Molecular Diagnostics and Staging: BSTB: Molecular Diagnostics and Staging Posters, Mon, Sept 3
• Poster Abstracts: BSTB: Molecular Pathology: BSTB: Molecular Pathology Posters, Wed, Sept 5 - Thur, Sept 6
• Poster Abstracts: BSTB: Molecular Targets: BSTB: Molecular Targets Posters, Tue, Sept 4
• Poster Abstracts: BSTB: Others: BSTB: Others Posters, Tue, Sept 4
• Poster Abstracts: BSTB: Prognostic Factors: BSTB: Prognostic Factors Posters, Tue, Sept 4
• Poster Abstracts: BSTB: Radiation Biology: BSTB: Radiation Biology Posters, Tue, Sept 4
• Poster Abstracts: BSTB: Tumor and Cell Biology: BSTB: Tumor and Cell Biology Posters, Tue, Sept 4
• Poster Abstracts: Chest Medicine and Intervention: Chest Medicine and Intervention Posters, Mon, Sept 3
• Poster Abstracts: Epidemiology and Tobacco Control: Epidemiology and Tobacco Control Posters, Mon, Sept 3
• Poster Abstracts: Imaging and Staging: Imaging and Staging Posters, Mon, Sept 3
• Poster Abstracts: Imaging and Staging: Posters, Mon, Sept 3
• Poster Abstracts: Mesothelioma and Other Thoracic Malignancy: Mesothelioma and Other Thoracic Malignancy Posters, Mon, Sept 3
• Poster Abstracts: Mesothelioma and Other Thoracic Malignancy Posters, Mon, Sept 3
• Poster Abstracts: Novel Therapeutics: Cytotoxic Chemotherapy: NT: Cytotoxic Chemotherapy Posters, Wed, Sept 5 - Thur, Sept 6
• Poster Abstracts: Novel Therapeutics: Immunotherapy/Vaccines: NT: Immunotherapy/Vaccines Posters, Wed, Sept 5 - Thur, Sept 6
• Poster Abstracts: Novel Therapeutics: Immunotherapy/Vaccines: NT: Molecular Therapeutics Posters, Wed, Sept 5 - Thur, Sept 6
• Poster Abstracts: Novel Therapeutics: New Horizon and Others: NT: New Horizon and Others Posters, Wed, Sept 5 - Thur, Sept 6
• Poster Abstracts: Novel Therapeutics:New Horizon and Others: NT: New Horizon and Others Posters, Wed, Sept 5 - Thur, Sept 6
• Poster Abstracts: Novel Therapeutics:New Horizon and Others: NT: Radiation Posters, Wed, Sept 5 - Thur, Sept 6
• Poster Abstracts: Novel Therapeutics: Surgery: RFA Etc.: Novel Therapeutics: NT: Surgery: RFA Etc. Posters, Wed, Sept 5 - Thur, Sept 6
• Poster Abstracts: Novel Therapeutics: Surgery: RFA Etc.: NT: Surgery: RFA Etc. Posters, Wed, Sept 5 - Thur, Sept 6
• Poster Abstracts: NSCLC: Combined Modality Therapy: NSCLC: Combined Modality Therapy Posters, Tue, Sept 4
• Poster Abstracts: NSCLC: Cytotoxic Chemotherapy: NSCLC: Cytotoxic Chemotherapy Posters, Tue, Sept 4
• Poster Abstracts: NSCLC: Molecular Targeted Therapy: NSCLC: Molecular Targeted Therapy Posters, Wed, Sept 5 - Thurs, Sept 6
• Poster Abstracts: NSCLC: Radiation: NSCLC: Radiation Posters, Wed, Sept 5 - Thurs, Sept 6
• Poster Abstracts: NSCLC: Surgery: NSCLC: Surgery Posters, Wed, Sept 5 - Thur, Sept 6
• Poster Abstracts: Pathology: Pathology Posters, Mon, Sept 3
• Poster Abstracts: Prevention and Early Detection
• Poster Abstracts: Prevention and Early Detection: Prevention and Early Detection Posters, Mon, Sept 3
• Poster Abstracts: SCLC: Combined Modality Therapy: SCLC: Combined Modality Therapy Posters, Mon, Sept 3
• Poster Abstracts: SCLC: Cytotoxic Chemotherapy: SCLC: Cytotoxic Chemotherapy Posters, Mon, Sept 3
• Poster Abstracts: SCLC: Molecular Targeted Therapy: SCLC: Molecular Targeted Therapy Posters, Mon, Sept 3
• Poster Abstracts: SCLC: Radiation: SCLC: Radiation Posters, Mon, Sept 3
• Poster Abstracts: SCLC: Surgery: SCLC: Surgery Posters, Mon, Sept 3
• Poster Abstracts: Supportive Care/QOL: Supportive Care/QOL Posters, Mon, Sept 3
• Poster Abstracts: Supportive Care/QOL: NSCLC: Cytotoxic Chemotherapy Posters, Tue, Sept 4
• Poster Abstracts: Author Index: PDF Only